Landscape Capital Management
PALI icon

Landscape Capital Management’s Palisade Bio PALI Stock Holding History

Landscape Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.2K Sell
17,922
-418,804
-96% -$817K ﹤0.01% 580
2026
Q2 		$913K Buy
436,726
+111,707
+34% +$220K 0.06% 413
2026
Q1 		$569K Buy
+325,019
New +$591K 0.04% 484

Other funds holding PALI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Landscape Capital Management's PALI Position: Q3 2026 in Review

Landscape Capital Management reduced its Palisade Bio (PALI) stake by 96% in Q3 2026, selling an estimated $817K and leaving 17,922 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Landscape Capital Management first reported a position in PALI in Q1 2026 and has held it in 3 quarters since. The position peaked at $913K in Q2 2026. 71 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Landscape Capital Management held 17,922 shares of Palisade Bio worth $24.2K as of Q3 2026.
  • Landscape Capital Management sold 418,804 Palisade Bio shares in Q3 2026, an estimated $817K.
  • Palisade Bio made up ﹤0.01% of Landscape Capital Management's portfolio in Q3 2026, its #580 holding.
  • Landscape Capital Management first reported a position in Palisade Bio in Q1 2026 and has held it in 3 quarters since.
  • Landscape Capital Management's Palisade Bio position peaked at $913K in Q2 2026.
  • 71 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.